China Approves Two More Domestic COVID-19 Vaccines, Increasing Number To Four-Reuters

China’s National Medical Products Administration said on Thursday that it had approved two more COVID-19 vaccines for public use, increasing the number of domestic vaccines approved in China to four. The two newly approved vaccines are made by CanSino Biologics Inc and Wuhan Institute of Biological Products, an affiliate of China National Pharmaceutical Group (Sinopharm). Reuters, 02/25/2021

•   Print
•   Email
•   Share
•   Tweet